Clinical observation of Fascia Manipulation in the treatment of visual display terminal asthenopia

Guangzhou Medical University0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Aged 18-25 years, no gender limit;
•2. Meet the VDT diagnostic criteria;
•3. Those without organic lesions of the eyes and head;
•4. Those who have not been treated or have been treated with other drugs for more than 2 weeks;
•5. Proficient in the use of smart phones;
•6. Those who signed the informed consent;
•7. No history of head trauma or surgery.

•1. Subjects with poor compliance;
•2. Subjects with serious diseases (such as diabetes, liver and kidney disease and (or) heart disease, thyroid disease, adrenal disease);
•3. Those with other eye diseases (such as infectious conjunctivitis, glaucoma);
•4. Subjects diagnosed with presbyopia (the dominant eye's controlled width is less than 2.5 diopters (D));
•5. Subjects with uncorrected severe refractive errors in the dominant eye;
•6. Subjects who have undergone ophthalmic surgery;
•7. Subjects whose dominant eye can achieve the best corrected visual acuity advantage <1.0;
•8. Subjects with serious diseases (such as diabetes, liver disease, kidney disease and (or) heart disease, thyroid disease, adrenal disease);
•9. Subjects who often take drugs or health food that may have an effect on the eyes or are expected to use related drugs or health food during the study period;
•10. Subjects who may cause drug allergy;
•11. Those who plan or have participated in other clinical studies during this study within 3 months.

发起方

Guangzhou Medical University